So-Yoon Won

So-Yoon Won

Auto-generated profile, based on publicly available information

So-Yoon Won

Department of Biochemistry and Medical Research Center, Chungbuk National University, Cheongju, Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2016 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
LHLuke M. Healy
Luke M. Healy
GPGabrielle Perron
Gabrielle Perron
SWSo-Yoon Won
So-Yoon Won
MMMackenzie A Michell-Robinson
Mackenzie A Michell-Robinson
ARAyman Rezk
Ayman Rezk
JAJack P. Antel
Jack P. Antel
Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF-β compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF-β–treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF-β–treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair.

1 April 2018 in Clinical Immunology
Verified
Journal Article
Closed access
LHLuke M. Healy
Luke M. Healy
GPGabrielle Perron
Gabrielle Perron
SWSo-Yoon Won
So-Yoon Won
VRVijayaraghava T.S. Rao
Vijayaraghava T.S. Rao
MGMarie-Christine Guiot
Marie-Christine Guiot
JAJack P. Antel
Jack P. Antel

1 September 2020 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
KSKyoung-ha So
Kyoung-ha So
JCJai Ho Choi
Jai Ho Choi
JIJaisan Islam
Jaisan Islam
EKElina Kc
Elina Kc
HMHyeong Cheol Moon
Hyeong Cheol Moon
YPYoung Seok Park
Young Seok Park
No optimum genetic rat Huntington model both neuropathological using an adeno-associated virus (AAV-2) vector vector has been reported to date. We investigated whether direct infection of an AAV2 encoding a fragment of mutant huntingtin (AV2-82Q) into the rat striatum was useful for optimizing the Huntington rat model. We prepared ten unilateral models by injecting AAV2-82Q into the right striatum, as well as ten bilateral models. In each group, five rats were assigned to either the 2×1012 genome copies (GC)/mL of AAV2-82Q (×1, low dose) or 2×1013 GC/mL of AAV2-82Q (×10, high dose) injection model. Ten unilateral and ten bilateral models injected with AAV-empty were also prepared as control groups. We performed cylinder and stepping tests 2, 4, 6, and 8 weeks after injection, tested EM48 positive mutant huntingtin aggregates. The high dose of unilateral and bilateral AAV2-82Q model showed a greater decrease in performance on the stepping and cylinder tests. We also observed more prominent EM48-positive mutant huntingtin aggregates in the medium spiny neurons of the high dose of AAV2-82Q injected group. Based on the results from the present study, high dose of AAV2-82Q is the optimum titer for establishing a Huntington rat model. Delivery of high dose of human AAV2-82Q resulted in the manifestation of Huntington behaviors and optimum expression of the huntingtin protein in vivo.

5 April 2016 in Neurology
Verified
Journal Article
Closed access
LHLuke M. Healy
Luke M. Healy
GPGabrielle Perron
Gabrielle Perron
SWSo-Yoon Won
So-Yoon Won
CMCraig S. Moore
Craig S. Moore
ABAmit Bar-Or
Amit Bar-Or
JAJack Antel
Jack Antel